Singapore markets closed
Straits Times Index
3,090.31 +17.32 (+0.56%) Nikkei
33,431.51 -55.38 (-0.17%) Hang Seng
16,830.30 -212.58 (-1.25%) FTSE 100
7,529.35 +75.60 (+1.01%) Bitcoin USD
38,785.38 +679.77 (+1.78%) CMC Crypto 200
802.76 +11.20 (+1.41%)
bioMérieux S.A. (BMXMF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 11:11AM EST
| Previous close | 106.36 |
| Open | 105.56 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 105.56 - 108.95 |
| 52-week range | 90.23 - 110.00 |
| Volume | |
| Avg. volume | 61 |
| Market cap | 12.87B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 30.78 |
| EPS (TTM) | 3.54 |
| Earnings date | N/A |
| Forward dividend & yield | 0.91 (0.84%) |
| Ex-dividend date | 06 Jun 2023 |
| 1y target est | N/A |
Business WireOxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics
OXFORD, England & MARCY-L’ETOILE, France, April 14, 2023--Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the field of in vitro diagnostics, today announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.
© 2023 Yahoo. All rights reserved.